Skip to main content

Table 1 Baseline patient characteristics

From: Effects of semaglutide on cardiovascular risk factors and eating behaviors in type 2 diabetes

  Mean and standard deviation or proportion
N 104
Age (years) 63.6 ± 10.4
Men (%) 58.7
Diabetes duration (years) 12.7 ± 8.7
BMI (Kg/m2) 32.9 ± 5.9
Smokers (%):  
No 66.3
Yes 26.9
Ex 6.7
HbA1c (%) 8.5 ± 1.8
Fasting blood glucose (mg/dl) 186.0 ± 60.0
Systolic blood pressure (mmHg) 135.8 ± 12.8
Diastolic blood pressure (mmHg) 79.6 ± 8.3
Total cholesterol (mg/dl) 190.3 ± 46.1
LDL cholesterol (mg/dl) 105.5 ± 39.5
HDL cholesterol (mg/dl) 44.8 ± 12.3
Non HDL cholesterol (mg/dl) 145.5 ± 44.7
Triglycerides (mg/dl) 200.0 ± 118.4
Hypertension (%) 61.2
Dyslipidemia (%) 100.0
Retinopathy (%) 9.6
Organ damage (%)* 51.0
Myocardial infarction (%) 10.6
Stroke (%) 2.9
Coronary rivascularization (%) 9.6
Heart failure (%) 2.9
eGFR < 60 ml/min*1.73 m2 5.8
Albuminuria > 300 mg/dl 1.0
  1. *Myocardial infarction, stroke, limb/feet amputation, coronary or peripheral revascularization, heart failure, carothid or peripheral vessels plaques, retinopathy, kidney damage markers (eGFR < 60, albuminuria > 300 mg/die, haemodialysis, kidney transplantation